Literature DB >> 24549104

Phosphodiesterase 10A regulates alcohol and saccharin self-administration in rats.

Marian L Logrip1, Leandro F Vendruscolo1, Joel E Schlosburg1, George F Koob1, Eric P Zorrilla1.   

Abstract

A history of stress produces increases in rodent relapse-like alcohol self-administration behavior and regional brain gene expression of phosphodiesterase 10A (PDE10A), a dual-specificity cyclic adenosine monophosphate/cyclic guanosine monophosphate-inhibiting enzyme. Here, we tested the hypothesis that administration of TP-10, a specific PDE10A inhibitor, would reduce alcohol self-administration in conditions predisposing to elevated self-administration. TP-10 administration dose-dependently (0.562, 1.0 mg/kg; subcutaneously) reduced relapse-like alcohol self-administration regardless of stress history enhancement of relapse-like behavior. TP-10 also reduced alcohol self-administration in genetically alcohol-preferring rats, as well as in alcohol-non-dependent and -dependent rats. Effective systemic TP-10 doses did not alter alcohol pharmacokinetics, significantly reduce motor activity or intrabout operant response speed, or promote a conditioned place aversion. TP-10 also reduced saccharin self-administration, suggesting a general role for PDE10A in the self-administration of reinforcing substances. PDE10A inhibition in the dorsolateral striatum, but not the nucleus accumbens, reduced alcohol self-administration. Taken together, the results implicate dorsolateral striatum PDE10A in facilitating alcohol intake and support further investigation of PDE10A systems in the pathophysiology and potential treatment of substance use disorders.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24549104      PMCID: PMC4023146          DOI: 10.1038/npp.2014.20

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  48 in total

1.  Cloning and characterization of a novel human phosphodiesterase that hydrolyzes both cAMP and cGMP (PDE10A).

Authors:  K Fujishige; J Kotera; H Michibata; K Yuasa; S Takebayashi; K Okumura; K Omori
Journal:  J Biol Chem       Date:  1999-06-25       Impact factor: 5.157

2.  To split behaviour into bouts, log-transform the intervals.

Authors: 
Journal:  Anim Behav       Date:  1999-04       Impact factor: 2.844

3.  Locomotor suppressive and anxiolytic-like effects of urocortin 3, a highly selective type 2 corticotropin-releasing factor agonist.

Authors:  Glenn R Valdez; Eric P Zorrilla; Jean Rivier; Wylie W Vale; George F Koob
Journal:  Brain Res       Date:  2003-08-08       Impact factor: 3.252

4.  Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases.

Authors:  Sung-Jun Park; Faiyaz Ahmad; Andrew Philp; Keith Baar; Tishan Williams; Haibin Luo; Hengming Ke; Holger Rehmann; Ronald Taussig; Alexandra L Brown; Myung K Kim; Michael A Beaven; Alex B Burgin; Vincent Manganiello; Jay H Chung
Journal:  Cell       Date:  2012-02-03       Impact factor: 41.582

5.  Corticosteroid-dependent plasticity mediates compulsive alcohol drinking in rats.

Authors:  Leandro F Vendruscolo; Estelle Barbier; Joel E Schlosburg; Kaushik K Misra; Timothy W Whitfield; Marian L Logrip; Catherine Rivier; Vez Repunte-Canonigo; Eric P Zorrilla; Pietro P Sanna; Markus Heilig; George F Koob
Journal:  J Neurosci       Date:  2012-05-30       Impact factor: 6.167

6.  Enduring sensorimotor gating abnormalities following predator exposure or corticotropin-releasing factor in rats: a model for PTSD-like information-processing deficits?

Authors:  Vaishali P Bakshi; Karen M Alsene; Patrick H Roseboom; Elenora E Connors
Journal:  Neuropharmacology       Date:  2011-02-01       Impact factor: 5.250

7.  The phosphodiesterase-4 (PDE4) inhibitor rolipram decreases ethanol seeking and consumption in alcohol-preferring Fawn-Hooded rats.

Authors:  Rui-Ting Wen; Min Zhang; Wang-Jun Qin; Qing Liu; Wei-Ping Wang; Andrew J Lawrence; Han-Ting Zhang; Jian-Hui Liang
Journal:  Alcohol Clin Exp Res       Date:  2012-06-04       Impact factor: 3.455

8.  Phosphodiesterase 10A inhibition modulates the sensitivity of the mesolimbic dopaminergic system to D-amphetamine: involvement of the D1-regulated feedback control of midbrain dopamine neurons.

Authors:  Florence Sotty; Liliana P Montezinho; Björn Steiniger-Brach; Jacob Nielsen
Journal:  J Neurochem       Date:  2009-02-19       Impact factor: 5.372

9.  Evaluating the antipsychotic profile of the preferential PDE10A inhibitor, papaverine.

Authors:  M Weber; M Breier; D Ko; N Thangaraj; D E Marzan; N R Swerdlow
Journal:  Psychopharmacology (Berl)       Date:  2008-12-09       Impact factor: 4.530

10.  BDNF-mediated regulation of ethanol consumption requires the activation of the MAP kinase pathway and protein synthesis.

Authors:  Jerome Jeanblanc; Marian L Logrip; Patricia H Janak; Dorit Ron
Journal:  Eur J Neurosci       Date:  2012-11-28       Impact factor: 3.386

View more
  28 in total

Review 1.  TAK-063, a novel PDE10A inhibitor with balanced activation of direct and indirect pathways, provides a unique opportunity for the treatment of schizophrenia.

Authors:  Kazunori Suzuki; Haruhide Kimura
Journal:  CNS Neurosci Ther       Date:  2018-01-09       Impact factor: 5.243

2.  Diacylglycerol lipase disinhibits VTA dopamine neurons during chronic nicotine exposure.

Authors:  Matthew W Buczynski; Melissa A Herman; Ku-Lung Hsu; Luis A Natividad; Cristina Irimia; Ilham Y Polis; Holly Pugh; Jae Won Chang; Micah J Niphakis; Benjamin F Cravatt; Marisa Roberto; Loren H Parsons
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-11       Impact factor: 11.205

Review 3.  Building better strategies to develop new medications in Alcohol Use Disorder: Learning from past success and failure to shape a brighter future.

Authors:  Nazzareno Cannella; Massimo Ubaldi; Alessio Masi; Massimo Bramucci; Marisa Roberto; Angelo Bifone; Roberto Ciccocioppo
Journal:  Neurosci Biobehav Rev       Date:  2019-05-18       Impact factor: 8.989

Review 4.  Molecular mechanisms underlying alcohol-drinking behaviours.

Authors:  Dorit Ron; Segev Barak
Journal:  Nat Rev Neurosci       Date:  2016-07-21       Impact factor: 34.870

Review 5.  Commonalities and Distinctions Among Mechanisms of Addiction to Alcohol and Other Drugs.

Authors:  Angela R Ozburn; Aaron J Janowsky; John C Crabbe
Journal:  Alcohol Clin Exp Res       Date:  2015-10       Impact factor: 3.455

6.  Fibroblast Growth Factor 2 in the Dorsomedial Striatum Is a Novel Positive Regulator of Alcohol Consumption.

Authors:  Oren Even-Chen; Yossi Sadot-Sogrin; Ohad Shaham; Segev Barak
Journal:  J Neurosci       Date:  2017-08-08       Impact factor: 6.167

7.  Phosphodiesterase 4 inhibitors and drugs of abuse: current knowledge and therapeutic opportunities.

Authors:  Christopher M Olsen; Qing-Song Liu
Journal:  Front Biol (Beijing)       Date:  2016-10-17

8.  Transcriptional Regulators as Targets for Alcohol Pharmacotherapies.

Authors:  Antonia M Savarese; Amy W Lasek
Journal:  Handb Exp Pharmacol       Date:  2018

9.  Inhibition of phosphodiesterase 2 by Bay 60-7550 decreases ethanol intake and preference in mice.

Authors:  Jing Shi; Huaxia Liu; Jianchun Pan; Jie Chen; Nianping Zhang; Kaiping Liu; Ning Fei; James M O'Donnell; Han-Ting Zhang; Ying Xu
Journal:  Psychopharmacology (Berl)       Date:  2018-06-07       Impact factor: 4.530

10.  Inhibition of Glyoxalase 1 reduces alcohol self-administration in dependent and nondependent rats.

Authors:  Giordano de Guglielmo; Dana E Conlisk; Amanda M Barkley-Levenson; Abraham A Palmer; Olivier George
Journal:  Pharmacol Biochem Behav       Date:  2018-03-02       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.